7.
Gaining of synergies with Importfab, Welcare, LaboVar and Labomar Next in order to expand the portfolio and its commercial proposals, sharing the results achieved by the Research and Development function, as well as integrating marketing activities. Moreover, through its subsidiaries Importfab and Labomar Next, Labomar also seeks tap into the opportunities presented by the growing cannabis market for pharmaceutical use, in particular on the North American market.